Medco Research stock revives as bulls resuscitate their optimism Like a kangaroo with a hotfoot, West Los Angeles-based Medco Research stock has bounded up again on Wall Street, hitting 52-week highs after plummeting last fall. The seven-employee drug research firm'...

Medco Research Inc., a tiny Los Angeles-based pharmaceutical shop, is the mouse that roared on Wall Street. Last week Medco, whose eight employees research heart drugs, was rising in a bear market, nearing an all-time record $22 a share. With 9.1 million shares outsta...

Drug company is investigated after stock sales Medco Research Inc., the West Los Angeles-based drug research company, is under an investigation of undetermined scope and nature by the Securities and Exchange Commission, the Business Journal has learned. "The SEC con...

Medco Research gets patent for new heart dilation 1. the act of dilating or stretching. 2. dilatation.di·la·tion (d-l drug Medco Research Inc., the high-flying West Los Angeles-based drug research company, last week reported it has received U.S. Patent Of...

Details of key FDA warning letters released the weeks of Feb. 28 and March 6 that contain citations for validation. Each letter is $7 plus retrieval. By Mark McCartyHigh particle counts trip American Pharmaceutical FDA's inspection of the Melrose Park, IL, pl...

Medco said U.S. denied patent FDA approval is also lacking WEST LOS ANGELES -- Medco Research Inc., a publicly held medical products research company, last week announced that it has been denied a patent application for one if its key drugs, named Adenoscan. "Th...

RICHMOND, Va.--(BW HealthWire)--Nov. 16, 1999-- Discovery Therapeutics Inc. (DTI DTI - Danish Technological InstituteDTI - Dawe Charitable Trust (UK)DTI - Debt to Income (ratio)DTI - Deep Trench IsolationDTI - Defense Technology Incorporated & AssociatesDTI - Delaye...

West Los Angeles-based Medco Research Inc. last week issued 1.72 million new shares of stock at $27.50 each, netting $43.7 million which it plans to use to fund work on 10 drugs already under development. With 10.8 million shares outstanding, Medco now has a market ca...

Here is IP Think Tank's weekly selection of top intellectual property news breaking in the blogosphere and internet. Highlights this week included: copyright & trademark trolls, the constitutional challenge to Brazil's IP law, Norway & Croatia join the...

JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted tentative approval for the Company's ANDA for Adenosine cyclic adenosine monophosphate  a cyclic nucleotide, adenosine 3',5'-cyclic...

CHICAGO -- Williams-Labadie, part of the Publicis Healthcare Communications Group network, received a Silver Award at the 2008 In-Awe awards. The event was June 5 at the Adelphus Hotel in Dallas, Texas. ...

Business Editors, Legal Writers ...

Business Editors, Health/Medical Writers ...

American Pharmaceutical Partners, Inc. ...

-First A2A Adenosine Receptor Agonist Approved for Use in Identifying Coronary Artery Disease- ...

CHICAGO -- Williams-Labadie, part of the Publicis Communications Group network, announced today the appointment of Carly Gill to Account Service Manager for Astellas' Adenoscan account, reporting to Susan Fennema, Director, Operations. ...